56960-82-8 Usage
General Description
2-Amino-3-nitro-5-chloro-6-picoline is a chemical compound with the molecular formula C6H5N3O2Cl. It is a derivative of picoline, which is a nitrogen heterocyclic compound used as a building block in the pharmaceutical and agrochemical industries. 2-Amino-3-nitro-5-chloro-6-picoline is primarily used as an intermediate in the synthesis of pharmaceutical compounds. It has also been identified as a potential environmental contaminant and may pose a risk to aquatic organisms. The compound's chemical structure and properties make it valuable for various applications in chemical research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 56960-82-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,6 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 56960-82:
(7*5)+(6*6)+(5*9)+(4*6)+(3*0)+(2*8)+(1*2)=158
158 % 10 = 8
So 56960-82-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H6ClN3O2/c1-3-4(7)2-5(10(11)12)6(8)9-3/h2H,1H3,(H2,8,9)
56960-82-8Relevant articles and documents
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
-
, (2008/06/13)
Disclosed is a method of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma or hypoglycemia. The method comprises administering to an animal a compound of the formula: STR1 or a pharmaceutically acceptable salt thereof; wherein n is zero or 1; R 4, R 5, R 6 are independently hydrogen, nitro, amino, halo, haloalkyl, cyano, alkyl, cycloalkyl, alkenyl, alkynyl, azido, acylamino, alkylsulfonyl, aryl, substituted aryl, heteroaryl, alkoxy, trialkylsilyl-substituted alkoxy, aryloxy, substituted aryloxy, heteroaryloxy, a heterocyclic group, a heterocyclicoxy group, aralkoxy, or haloalkoxy; and R c and R d are defined in the specification. These compounds have high binding to the glycine site of the NMDA receptor.
